{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:27:02Z","timestamp":1789824422549,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T00:00:00Z","timestamp":1269388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s11940-010-0070-0","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T23:38:06Z","timestamp":1269301086000},"page":"231-243","source":"Crossref","is-referenced-by-count":21,"title":["Myasthenia Gravis"],"prefix":"10.1007","volume":"12","author":[{"given":"Agnes","family":"Jani-Acsadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Lisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,24]]},"reference":[{"key":"70_CR1","volume-title":"Myasthenia Gravis: An Illustrated History","author":"JC Keesey","year":"2002","unstructured":"Keesey JC: Myasthenia Gravis: An Illustrated History. Roseville: Publishers Design Group; 2002."},{"key":"70_CR2","doi-asserted-by":"crossref","unstructured":"Ohry A: Dr. Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis. J Med Biogr 17(2):73\u201374.","DOI":"10.1258\/jmb.2009.009003"},{"key":"70_CR3","doi-asserted-by":"crossref","unstructured":"Jaretzki A, Sonett JR: Thymectomy for non-thymomatous myasthenia gravis. In Myasthenia Gravis and Related Disorders, edn 2. Edited by Kaminski HJ. New York: Humana Press; 2008:185\u2013208. This chapter presents a detailed analysis of current expert opinion and controversies regarding thymectomy.","DOI":"10.1007\/978-1-59745-156-7_12"},{"key":"70_CR4","first-page":"143","volume-title":"Myasthenia Gravis and Related Disorders","author":"MA Agius","year":"2003","unstructured":"Agius MA, Richman DP, Vincent A: Autoantibody testing in the diagnosis and management of autoimmune disorders of neuromuscular transmission and related disorders. In Myasthenia Gravis and Related Disorders. By Kaminski HJ. Totowa: Humana; 2003:143\u2013156."},{"key":"70_CR5","doi-asserted-by":"crossref","unstructured":"Leite MI, Jacob S, Viegas S, et al.: IgG1 antibodies to acetylcholine receptors in \u201cseronegative\u201d myasthenia gravis. Brain 2008, 131(7):1940\u20131952. This paper proves the presence of low-affinity antibodies in \u201cseronegative\u201d MG and their role in complement activation at the neuromuscular junction.","DOI":"10.1093\/brain\/awn092"},{"key":"70_CR6","doi-asserted-by":"crossref","unstructured":"Kaminski HJ: Treatment of myasthenia gravis. In Myasthenia Gravis and Related Disorders, edn 2. Edited by Kaminski HJ. New York: Humana Press; 2008:157\u2013173. This chapter presents a concise overview of treatment options in autoimmune MG.","DOI":"10.1007\/978-1-59745-156-7_10"},{"issue":"3","key":"70_CR7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","volume":"41","author":"M Pasnoor","year":"2010","unstructured":"Pasnoor M, Wolfe GI, Nations S, et al.: Clinical findings in MuSK-antibody positive myasthenia gravis: A U.S. experience. Muscle Nerve 2010, 41(3):370\u2013374.","journal-title":"Muscle Nerve"},{"issue":"9","key":"70_CR8","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.clinph.2005.06.003","volume":"116","author":"DE Stickler","year":"2005","unstructured":"Stickler DE, Massey JM, Sanders DB: MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin Neurophysiol 2005, 116(9):2065\u20132068.","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"70_CR9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archneur.62.3.442","volume":"62","author":"F Romi","year":"2005","unstructured":"Romi F, Skeie GO, Gilhus NE: Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 2005, 62(3):442\u2013446.","journal-title":"Arch Neurol"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11940-999-0006-8","volume":"1","author":"RP Lisak","year":"1999","unstructured":"Lisak RP: Myasthenia gravis. Curr Treat Options Neurol 1999, 1:239\u2013249.","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"70_CR11","first-page":"34","volume":"15","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN: Myasthenia gravis: immunopathogenesis, diagnosis, and management. Continuum 2009, 15(1):34\u201362.","journal-title":"Continuum"},{"key":"70_CR12","first-page":"CD005224","volume":"4","author":"IK Hart","year":"2007","unstructured":"Hart IK, Sathasivam S, Sharshar T: Immunosuppressive agents for myasthenia gravis. Cochrane Database Syst Rev 2007, 4:CD005224.","journal-title":"Cochrane Database Syst Rev"},{"key":"70_CR13","first-page":"407","volume-title":"Current Therapy in Neurological Disease","author":"RP Lisak","year":"2002","unstructured":"Lisak RP: Myasthenia gravis. In Current Therapy in Neurological Disease. By Johnson RT, Griffin JW, McArthur JC. St. Louis: Mosby; 2002:407\u2013409."},{"key":"70_CR14","doi-asserted-by":"crossref","unstructured":"Jani-Acsadi A, Lisak RP: Myasthenic crisis: guidelines for prevention and treatment. J Neurol Sci 2007, 261(1\u20132):127\u2013133. This recent review of expert opinion on pharmacologic and interventional treatment options for myasthenic crisis emphasizes the role of plasma pheresis.","DOI":"10.1016\/j.jns.2007.04.045"},{"issue":"7","key":"70_CR15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","volume":"13","author":"GO Skeie","year":"2006","unstructured":"Skeie GO, Apostolski S, Evoli A, et al.: Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2006, 13(7):691\u2013699.","journal-title":"Eur J Neurol"},{"key":"70_CR16","doi-asserted-by":"crossref","unstructured":"Punga AR, Stalberg E: Acetylcholinesterase inhibitors in myasthenia gravis: to be or not to be? Muscle Nerve 2009, 39:724\u2013728. This is a concise review of the mechanisms, therapeutic effects, and contraindications of newer and older acetylcholinesterase inhibitors in MG.","DOI":"10.1002\/mus.21319"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-200721060-00004","volume":"21","author":"IB Kulaksizoglu","year":"2007","unstructured":"Kulaksizoglu IB: Mood and anxiety disorders in patients with myasthenia gravis: etiology, diagnosis and treatment. CNS Drugs 2007, 21:473\u2013481.","journal-title":"CNS Drugs"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","volume":"14","author":"JM Hoff","year":"2007","unstructured":"Hoff JM, Daltveit AK, Gilhus NE: Myasthenia gravis in pregnancy and birth: identifying risk factors, optimizing care. Eur J Neurol 2007, 14:38\u201343.","journal-title":"Eur J Neurol"},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2004-829590","volume":"24","author":"E Ciafaloni","year":"2004","unstructured":"Ciafaloni E, Massey JM: The management of myasthenia gravis in pregnancy. Semin Neurol 2004, 24:95\u2013100.","journal-title":"Semin Neurol"},{"key":"70_CR20","first-page":"CD006986","volume":"1","author":"MM Mehndiratta","year":"2008","unstructured":"Mehndiratta MM, Kuntzer T, Pandey S: Anticholinesterase treatment for myasthenia gravis. Cochrane Database Syst Rev 2008, 1:CD006986.","journal-title":"Cochrane Database Syst Rev"},{"key":"70_CR21","first-page":"CD002828","volume":"2","author":"C Schneider-Gold","year":"2005","unstructured":"Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR: Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005, 2:CD002828.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"70_CR22","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","volume":"50","author":"J Palace","year":"1998","unstructured":"Palace J, Newsom-Davis J, Lecky B: A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology 1998, 50(6):1778\u20131783.","journal-title":"Neurology"},{"key":"70_CR23","volume-title":"Myasthenia Gravis: The Immunobiology of an Autoimmune Disease","author":"B Conti-Fine","year":"1997","unstructured":"Conti-Fine B: Myasthenia Gravis: The Immunobiology of an Autoimmune Disease. Austin: Landes Bioscience; 1997."},{"key":"70_CR24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.55.3.448","volume":"55","author":"E Ciafaloni","year":"2000","unstructured":"Ciafaloni E, Nikhar NK, Massey JM, Sanders DB: Retrospective analysis of the use of cyclosporine in the treatment of myasthenia gravis. Neurology 2000, 55:448\u2013450.","journal-title":"Neurology"},{"issue":"6","key":"70_CR25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","volume":"71","author":"DB Sanders","year":"2008","unstructured":"Sanders DB, Hart IK, Mantegazza R, et al.: An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 2008, 71(6):400\u2013406.","journal-title":"Neurology"},{"issue":"24","key":"70_CR26","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1212\/01.wnl.0000263481.14289.90","volume":"68","author":"M Benatar","year":"2007","unstructured":"Benatar M, Kaminski HJ: Quality Standards Subcommittee of the American Academy of Neurology: Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007, 68(24):2144\u20132149.","journal-title":"Neurology"},{"key":"70_CR27","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1212\/01.WNL.0000160392.32894.6D","volume":"64","author":"JM Ponseti","year":"2005","unstructured":"Ponseti JM, Azem J, Fort JM, et al.: Long-term results of tacrolimus in cyclosporine\u2014and prednisone-dependent myasthenia gravis. Neurology 2005, 64:1641\u20131643.","journal-title":"Neurology"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1196\/annals.1405.000","volume":"1132","author":"JM Ponseti","year":"2008","unstructured":"Ponseti JM, Gamez J, Azem J, et al.: Tacrolimus for myasthenia gravis: a clinical study of 212 patients. Ann NY Acad Sci 2008, 1132:254\u2013263.","journal-title":"Ann NY Acad Sci"},{"key":"70_CR29","unstructured":"The utility of therapeutic plasmapheresis for neurological disorders. NIH Consens Statement 1986, 6(4):1\u20137."},{"key":"70_CR30","first-page":"CD002275","volume":"4","author":"P Gajdos","year":"2002","unstructured":"Gajdos P, Chevret S, Toyka K: Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 2002, 4:CD002275.","journal-title":"Cochrane Database Syst Rev"},{"key":"70_CR31","first-page":"CD002277","volume":"1","author":"P Gajdos","year":"2008","unstructured":"Gajdos P, Chevret S, Toyka K: Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev 2008, 1:CD002277.","journal-title":"Cochrane Database Syst Rev"},{"key":"70_CR32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1212\/WNL.52.3.629","volume":"52","author":"AI Qureshi","year":"1999","unstructured":"Qureshi AI, Choudhry MA, Akbar MS, et al.: Plasma exchange versus intravenous immunoglobuline treatment in myasthenic crisis. Neurology 1999, 52:629\u2013632.","journal-title":"Neurology"},{"key":"70_CR33","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","volume":"59","author":"A Evoli","year":"2002","unstructured":"Evoli A, Minisci C, Di Schino C, et al.: Thymoma in patients with MG: characteristics and long-term outcome. Neurology 2002, 59:1844\u20131850.","journal-title":"Neurology"},{"key":"70_CR34","first-page":"CD008111","volume":"4","author":"G Cea","year":"2009","unstructured":"Cea G, Benatar M, Verdugo RJ, Salinas RA: Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev 2009, 4:CD008111.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"70_CR35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpedsurg.2005.10.006","volume":"41","author":"AJ Wagner","year":"2006","unstructured":"Wagner AJ, Cortes RA, Strober J, et al.: Long-term follow-up after thymectomy for myasthenia gravis: thoracoscopic vs open. J Pediatr Surg 2006, 41(1):50\u201354.","journal-title":"J Pediatr Surg"},{"key":"70_CR36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1196\/annals.1405.013","volume":"1132","author":"JA R\u00fcckert","year":"2008","unstructured":"R\u00fcckert JA, Ismail M, Swierzy M, et al.: Thoracoscopic thymectomy with the da Vinci robotic system for myasthenia gravis. Ann NY Acad Sci 2008, 1132:329\u2013335.","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"70_CR37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1010-7940(03)00299-9","volume":"24","author":"M Essaa","year":"2003","unstructured":"Essaa M, El-Medanya Y, Hajjara W, et al.: Maximal thymectomy in children with myasthenia gravis. Eur J Cardiothorac Surg 2003, 24(2):187\u2013191.","journal-title":"Eur J Cardiothorac Surg"},{"key":"70_CR38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1196\/annals.1405.004","volume":"1132","author":"JR Sonett","year":"2008","unstructured":"Sonett JR, Jaretzki A: Thymectomy for nonthymomatous myasthenia gravis: a critical analysis. Ann N Y Acad Sci 2008, 1132:315\u2013328.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"70_CR39","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.athoracsur.2009.07.036","volume":"88","author":"C Prokakis","year":"2009","unstructured":"Prokakis C, Koletsis E, Salakou S, et al.: Modified maximal thymectomy for myasthenia gravis: effect of maximal resection on late neurologic outcome and predictors of disease remission. Ann Thorac Surg 2009, 88(5):1638\u20131645.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"70_CR40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1510\/icvts.2009.214635","volume":"9","author":"A Toker","year":"2009","unstructured":"Toker A, Tanju S, Ziyade S, et al.: Early outcomes of video-assisted thoracoscopic resection of thymus in 181 patients with myasthenia gravis: Who are the candidates for the next morning discharge? Interact Cardiovasc Thorac Surg 2009, 9(6):995\u2013998.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"5","key":"70_CR41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ejcts.2008.07.049","volume":"34","author":"JM Ponseti","year":"2008","unstructured":"Ponseti JM, Gamez J, Vilallonga R, et al.: Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis. Eur J Cardiothorac Surg 2008, 34(5):1062\u20131067.","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0070-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-010-0070-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0070-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:55Z","timestamp":1559422615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-010-0070-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,24]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s11940-010-0070-0","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,24]]}}}